CoChat

All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials

Kim, Jeongseon, Hoang, Tung, Kim, Ji-Myung, Bu, So Young, Choi, Jeong-Hwa, Park, Eunju, Lee, Seung-Min, Park, Eunmi, Min, Ji Yeon, Lee, In Seok, Youn, So Young, Yeon, Jee-Young · 2020 · Nutrients
Cited by 8

The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.

Abstract

Statins and omega-3 supplementation have shown potential benefits in preventing cardiovascular disease (CVD), but their comparative effects on mortality outcomes, in addition to primary and secondary prevention and mixed population, have not been investigated. This study aimed to examine the effect of statins and omega-3 supplementation and indirectly compare the effects of statin use and omega-3 fatty acids on all-cause mortality and CVD death. We included randomized controlled trials (RCTs) from meta-analyses published until December 2019. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were calculated to indirectly compare the effect of statin use versus omega-3 supplementation in a frequentist network meta-analysis. In total, 55 RCTs were included in the final analysis. Compared with placebo, statins were significantly associated with a decreased the risk of all-cause mortality (RR = 0.90, 95% CI = 0.86–0.94) and CVD death (RR = 0.86, 95% CI = 0.80–0.92), while omega-3 supplementation showed a borderline effect on all-cause mortality (RR = 0.97, 95% CI = 0.94–1.01) but were significantly associated with a reduced risk of CVD death (RR = 0.92, 95% CI = 0.87–0.98) in the meta-analysis. The network meta-analysis found that all-cause mortality was significantly different between statin use and omega-3 supplementation for overall population (RR = 0.91, 95% CI = 0.85–0.98), but borderline for primary prevention and mixed population and nonsignificant for secondary prevention. Furthermore, there were borderline differences between statin use and omega-3 supplementation in CVD death in the total population (RR = 0.92, 95% CI = 0.82–1.04) and primary prevention (RR = 0.85, 95% CI = 0.68–1.05), but nonsignificant differences in secondary prevention (RR = 0.97, 95% CI = 0.66–1.43) and mixed population (RR = 0.92, 95% CI = 0.75–1.14). To summarize, statin use might be associated with a lower risk of all-cause mortality than omega-3 supplementation. Future direct comparisons between statin use and omega-3 supplementation are required to confirm the findings.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu12103203

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure A1 Subgroup meta-analysis for the effect of statin use on primary or secondary prevention of all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A1 Subgroup meta-analysis for the effect of statin use on primary or secondary prevention of all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A2 Subgroup meta-analysis for the effect of different statins on all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A2 Subgroup meta-analysis for the effect of different statins on all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A3 Subgroup meta-analysis for the effect of statin use on primary or secondary prevention of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A3 Subgroup meta-analysis for the effect of statin use on primary or secondary prevention of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A4 Subgroup meta-analysis for the effect of different statins on cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A4 Subgroup meta-analysis for the effect of different statins on cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A5 Subgroup meta-analysis for the effect of omega-3 supplementation on primary or secondary prevention of all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A5 Subgroup meta-analysis for the effect of omega-3 supplementation on primary or secondary prevention of all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A6 Subgroup meta-analysis for the effect of different omega-3 supplementation types on all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A6 Subgroup meta-analysis for the effect of different omega-3 supplementation types on all-cause mortality. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A7 Subgroup meta-analysis for the effect of omega-3 supplementation on primary or secondary prevention of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A7 Subgroup meta-analysis for the effect of omega-3 supplementation on primary or secondary prevention of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A8 Subgroup meta-analysis for the effect of different omega-3 supplementation types on cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A8 Subgroup meta-analysis for the effect of different omega-3 supplementation types on cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid. ALA, alpha-linolenic acid. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A9 Funnel plot analysis to detect publication bias: (A) statins and all-cause mortality; (B) statins and cardiovascular disease death; (C) omega-3 supplementation and all-cause mortality; and (D) omega-3 supplementation and cardiovascular disease death). RR, relative risk; SE, standard error.
Figure A9 Funnel plot analysis to detect publication bias: (A) statins and all-cause mortality; (B) statins and cardiovascular disease death; (C) omega-3 supplementation and all-cause mortality; and (D) omega-3 supplementation and cardiovascular disease death). RR, relative risk; SE, standard error.CC BY · PubMed Central
Figure A10 Subgroup meta-analysis for the effect of statins on specific causes of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A10 Subgroup meta-analysis for the effect of statins on specific causes of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A11 Subgroup meta-analysis for the effect of omega-3 supplementation on specific causes of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.
Figure A11 Subgroup meta-analysis for the effect of omega-3 supplementation on specific causes of cardiovascular disease death. Full black quadrilateral represents the point estimate of individual studies and blank with quadrilateral represents pooled estimates. RR, relative risk; CI, confidence interval. Pooled estimates for the overall study population and subgroups are highlighted with bold font.CC BY · PubMed Central
Figure A12 Dose–response meta-analysis of the association between (A) atorvastatin, (B) pravastatin, (C) simvastatin, (D) rosuvastain, (E) lovastatin, and (F) omega-3 supplementation with all-cause mortality.
Figure A12 Dose–response meta-analysis of the association between (A) atorvastatin, (B) pravastatin, (C) simvastatin, (D) rosuvastain, (E) lovastatin, and (F) omega-3 supplementation with all-cause mortality.CC BY · PubMed Central
Figure A13 Dose–response meta-analysis of the association between (A) atorvastatin, (B) pravastatin, (C) simvastatin, (D) rosuvastain, (E) fluvastatin, and (F) omega-3 supplementation with cardiovascular death.
Figure A13 Dose–response meta-analysis of the association between (A) atorvastatin, (B) pravastatin, (C) simvastatin, (D) rosuvastain, (E) fluvastatin, and (F) omega-3 supplementation with cardiovascular death.CC BY · PubMed Central
Figure 1 Flowchart of search strategy and study selection.
Figure 1 Flowchart of search strategy and study selection.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Research works printed but not linked: 7

  1. Arnett, 2019, 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines, Circulation, 140, e596
  2. Bikdeli, 2014, Omega-3 supplements and cardiovascular diseases, Tanaffos, 13, 6
  3. Abdelhamid, 2018, Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst. Rev., 7, CD003177
  4. Gissi, 1999, Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico, Lancet, 354, 447, 10.1016/S0140-6736(99)07072-5 · DOI · Paper page
  5. Koren, 2004, Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: The alliance study, J. Am. Coll Cardiol., 44, 1772
  6. Karam, 2008, High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators, N. Engl. J. Med., 3, 68
  7. Scandinavian Simvastatin Survival Study Group (1994). Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1383–1389. · DOI · Paper page

Cited by

See all 8

Metadata

Authors
Kim, J., Hoang, T., Kim, J.-M., Bu, S. Y., Choi, J.-H., Park, E., Lee, S.-M., Park, E., Min, J. Y., Lee, I. S., Youn, S. Y., & Yeon, J.-Y.
Affiliations
  • Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Korea
  • Food and Nutrition Major, Division of Food Science and Culinary Arts, Shinhan University, Uijeongbu 11644, Korea
  • Department of Food and Nutrition, Daegu University, Gyeongsan 38453, Korea
  • Department of Food and Nutrition, Keimyung University, Daegu 42601, Korea
  • Department of Food and Nutrition, Kyungnam University, Changwon 51767, Korea
  • Department of Food and Nutrition, Yonsei University, Seoul 03722, Korea
  • Department of Food and Nutrition, Hannam University, Daejeon 34430, Korea
  • Dietetics and Nutrition Services Team, Asan Medical Center, Seoul 05505, Korea
  • Nutrition Support Team, Kyung Hee University Medical Center, Seoul 02447, Korea
  • Clinical Nutrition Part, Samsung Medical Center, Seoul 06351, Korea
  • Department of Food and Nutrition, Seowon University, Cheongju 28674, Korea
Venue
Nutrients
Publisher
MDPI AG
Published
2020-10-20
Volume
12
Issue
10
Pages
3203
ISSN
2072-6643
Cited by
8
References
82
Language
en
Funders
  • Korean Society of Lipid and Atherosclerosis (NA)
  • National Cancer Center, Korea (1910330)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials. https://app.cochat.ai/papers/10.3390/nu12103203
The paper
Kim, J., Hoang, T., Kim, J.-M., Bu, S. Y., Choi, J.-H., Park, E., Lee, S.-M., Park, E., Min, J. Y., Lee, I. S., Youn, S. Y., & Yeon, J.-Y. (2020). All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials. Nutrients. https://doi.org/10.3390/nu12103203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.